The frequency of KRAS-mutation(+) did not increase significantly in cancer compared with that in adenoma and a significant correlation between intermediate-methylation and KRAS-mutation(+) was already detected at the adenoma stage (Figure 5A). The gene discussed is KRAS; the disease is adenoma.